DAX23.831 -1,8%Est505.607 -0,8%MSCI World4.297 +0,1%Top 10 Crypto14,33 -4,0%Nas22.681 +0,5%Bitcoin91.465 -1,0%Euro1,1668 -0,2%Öl61,22 +0,3%Gold4.236 -2,1%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 DroneShield A2DMAA NVIDIA 918422 RENK RENK73 Novo Nordisk A3EU6F Deutsche Bank 514000 D-Wave Quantum A3DSV9 Allianz 840400 Plug Power A1JA81 HENSOLDT HAG000 thyssenkrupp 750000 Tesla A1CX3T Amazon 906866 Siemens Energy ENER6Y BASF BASF11
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
US-Börsen mit leichtem Rebound -- DAX geht unter 24.000-Punkte-Marke ins Wochenende -- Conti übertrifft Prognosen -- BYD, Novo Nordisk, Diginex, European Lithium, Gold, Bitcoin, HPE, Meta im Fokus
Top News
Favoriten der Finanzprofis: Diese Aktien empfehlen Experten zu kaufen Favoriten der Finanzprofis: Diese Aktien empfehlen Experten zu kaufen
Das hat den NVIDIA-Chef am Deal zwischen OpenAI und AMD überrascht Das hat den NVIDIA-Chef am Deal zwischen OpenAI und AMD überrascht
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil
ZertifikateAwards: Jetzt für finanzen.net zero abstimmen und eine Reise nach Berlin gewinnen!

Quest Diagnostics Aktie

Kaufen
Verkaufen
Aktien-Sparplan anlegen
160,40 EUR +0,35 EUR +0,22 %
STU
189,51 USD +2,70 USD +1,45 %
BTT
Quest Diagnostics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.17,89 Mrd. EUR

KGV19,69Div. Rendite1,99%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN904533

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS74834L1008

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolDGX

Quest Diagnostics Aktien News

DatumMeistgelesen
PR NewswireMVZ HPH Brings ctDNA Blood Test for Cancer Monitoring to Europe, Based on Haystack MRD® Technology from Quest Diagnostics®
PR NewswireQuest Diagnostics to Release Third Quarter 2025 Financial Results on October 21, 2025
PR NewswireQuest Diagnostics to Improve Laboratory Testing Experience with Industry-First Epic Collaboration
Wer­bungQuest Diagnostics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireHaystack Oncology and Rutgers Cancer Institute Collaborate in a Clinical Study to Examine Haystack MRD as a Guide for Post-Surgical Treatment for Lung Cancer
PR NewswireQuest Diagnostics to Speak at the Jefferies Healthcare Services Conference
PR NewswireQuest Diagnostics Launches Advanced Pharmacogenomics (PGx) Offering
PR NewswireFentanyl Positivity Is More Than Seven Times Higher in Random Tests vs. Pre-Employment Drug Screening, Finds 2025 Quest Diagnostics Drug Testing Index
PR NewswireCorewell Health and Quest Diagnostics to Enter into Joint Venture Providing Enhanced Laboratory Services in Michigan
PR NewswireFDA Grants Breakthrough Device Designation for Haystack MRD Circulating Tumor DNA Test from Quest Diagnostics
PR NewswireQuest Diagnostics to Speak at the Baird 2025 Global Healthcare Conference
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireMass General Brigham Launches Two Clinical Trials to Study Haystack MRD ctDNA as Guide for Post-surgical Treatment for Two Cancer Types
PR NewswireQuest Diagnostics Completes Acquisition of Clinical Testing Assets from Fresenius Medical Care
PR NewswireAthena Diagnostics Improves Ataxia Movement Disorder Testing with Novel Long-Read Gene Sequencing
PR NewswireQuest Diagnostics Reports Second Quarter 2025 Financial Results; Raises Guidance for Full Year 2025
PR NewswireQuest Diagnostics Introduces Testing for Oropouche Virus
PR NewswireQuest Diagnostics to Offer FDA-Cleared Fujirebio Blood Test for Alzheimer's Disease
PR NewswireQuest Diagnostics Releases 2024 Corporate Responsibility Report
PR NewswireQuest Diagnostics to Release Second Quarter 2025 Financial Results on July 22, 2025
PR NewswireQuest Diagnostics to Develop Multi-cancer Stratification (MCaST) Blood Test Based on MD Anderson Technology
PR NewswireMore Americans Know Their Streaming Platform Passwords by Heart Than Their Cholesterol Score, New Survey Reveals
PR NewswireQuest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend
PR NewswireOncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds
PR NewswireQuest Diagnostics Reports First Quarter 2025 Financial Results; Reaffirms Revenue and Adjusted Diluted EPS Guidance for Full Year 2025
PR NewswireQuest Diagnostics Launches New AD-Detect™ Blood Test to Aid in Confirming Alzheimer's Disease
PR NewswireQuest Diagnostics to Release First Quarter 2025 Financial Results on April 22, 2025
PR NewswireQuest Diagnostics to Highlight Strategic Priorities to Drive Sustainable Growth and Deliver Long-term Shareholder Value at 2025 Investor Day
PR NewswireQuest Diagnostics to Collaborate with Google Cloud to Streamline Data and Personalize Customer Experiences Using Generative AI
PR NewswireFresenius Medical Care Announces Divestment of Select Laboratory Assets to Quest Diagnostics
PR NewswireQuest Diagnostics to Host Investor Day on March 19, 2025
PR NewswireGRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System
PR NewswireQuest Diagnostics Named to Fortune's World's Most Admired Companies List for 11th Consecutive Year
PR NewswireQuest Diagnostics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Guidance for Full Year 2025; Increases Quarterly Dividend 6.7% to $0.80 Per Share
PR NewswireQuest Diagnostics Completes Acquisition of the Outreach Lab Services Business of University Hospitals
PR NewswireQuest Diagnostics Names Adrienne Brott Senior Vice President and Chief Quality and Regulatory Affairs Officer
PR NewswireQuest Diagnostics to Release Fourth Quarter and Full Year 2024 Financial Results on January 30, 2025
PR NewswireQuest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference
PR NewswireQuest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health
PR NewswireQuest Diagnostics Declares Quarterly Cash Dividend

Quest Diagnostics News

Quest Diagnostics News: auf dieser Seite finden Sie alle Quest Diagnostics News und Nachrichten zur Quest Diagnostics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Quest Diagnostics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Quest Diagnostics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.